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Purpose. Hypothermic machine perfusion systems seem more effective than the current static storage to prevent cold ischemic liver
injury. Thus, we test an innovative hyperbaric hypothermic machine perfusion (HHMP), which combines hyperbaric oxygenation
of the preservation solution and continuous perfusion of the graft. Methods. Rat livers were preserved with Celsior solution accord-
ing to 4 different modalities: normobaric static preservation; hyperbaric static preservation at 2 atmosphere absolute (ATA); normo-
baric dynamic preservation, with continuous perfusion; hyperbaric dynamic preservation, with continuous perfusion at 2 ATA. After
24 h cold preservation, we assessed different parameters. Results. Compared to baseline, livers preserved with the current static
storage showed severe ultrastructural damage, glycogen depletion and an increased oxidative stress. Normobaric perfused livers
showed improved hepatocyte ultrastructure and ameliorated glycogen stores, but they still suffered a significant oxidative damage.
The addition of hyperbaric oxygen produces an extra benefit by improving oxidative injury and by inducing endothelial NO syn-
thase (eNOS) gene expression. Conclusions. Preservation bymeans of the present innovative HHMP reduced the liver injury occur-
ring after the current static cold storage by lowering glycogen depletion and oxidative damage. Interestingly, only the use of hyper-
baric oxygen was associated to a blunted oxidative stress and an increased eNOS gene expression.
1. Introduction
The prevention of preservation injury is crucial to accom-
plish the early recovery of cellular metabolism after trans-
plantation and to avoid graft dysfunction. To bridge the time-
span from the harvesting to the implantation in the recipient,
the livers are stored in preservation solutions on melting
ice at 0–4◦C, allowing a safe preservation up to 12 h [1]. A
cold ischemia longer than 12 h still implies a greater risk of
graft dysfunction. Furthermore, the rising demand for trans-
plantation triggers the use of the so-called extended criteria
donors, which tolerate a period of cold ischemia even shorter
than 12 hours [2].
Alteration of the energy metabolism is an important
feature of preservation injury [3]. Hypothermia at 0–4◦C is
a key factor for organ preservation by reducing the cellular
metabolic activity about 90–95% [4]. However, even at this
low temperature, metabolism still requires 0.27mol oxygen/
min/g of liver [4], which is not provided by the current static
storage. Oxygen is mainly taken up by mitochondria to allow
the synthesis of adenosine triphosphate (ATP); therefore,
the lack of oxygen results in failure of the respiratory chain
and ATP can solely be generated through the anaerobic
glycolysis. Once the cellular glycogen stores are consumed,
ATP depletion rapidly ensues leading to a series of events
which eventually cause irreversible cell injury and death [5].
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In the last decade, experimental studies have shown that
continuous perfusion of the liver during preservation can
improve graft viability and challenge the limits of the current
static storage [6–9]. However, several issues need to be clar-
ified before the hypothermic machine perfusion (HMP) will
reach the clinical application, including the type of preserva-
tion solution, the characteristics of perfusion dynamics, and
the modalities of oxygen supply [4, 9]. Regarding the latter
issue, oxygenation of the solution appears to be a typical
double-edge condition: the oxygen supplied during cold
ischemia should guarantee the ATP synthesis for the residual
metabolic activity, but, at the same time, it might favor the
generation of reactive oxygen species (ROS) leading to the
exacerbation of cellular injury.
Treatment with hyperbaric oxygen is a method that em-
ploys exposure to 100% oxygen at a pressure above 1 atmo-
sphere absolute (1 ATA) to promote tissue hyperoxygenation.
In the setting of liver diseases, hyperbaric oxygen has been
used to treat hepatic artery thrombosis after transplantation
and acute liver failure due to carbon tetrachloride intoxi-
cation [10, 11]. However, experimental data indicate that
hyperbaric oxygen is also capable to reduce hepatic warm
ischemia-reperfusion injury by interfering with several
pathogenic mechanisms [12–14]. It has been proposed that
hyperbaric oxygen counteracts neutrophil adhesion within
the microvasculature by downregulating the expression of
endothelial cell adhesion molecules, enhance nitric oxide
(NO) production by increasing the expression of endothelial
NO synthase (eNOS), prevents lipid peroxidation, and ame-
liorates the mitochondrial oxidative phosphorylation capac-
ity [12–14]. Finally, Ijichi et al. [15] have recently showed
that hyperbaric oxygen applied to the current static storage
ameliorates preservation injury and ATP depletion in rat
livers.
Based on these observations, we aimed to determine
whether an innovative hyperbaric hypothermicmachine per-
fusion (HHMP) that combines the oxygenation of the preser-
vation solution with hyperbaric oxygen to the continuous
perfusion of the graft improves rat liver preservation injury.
2. Materials andMethods
2.1. Hyperbaric Hypothermic Machine Perfusion (HHMP).
The HHMP, designed and patented by “Centro Iperbarico
s.r.l.,” Ravenna, Italy, consists of a hyperbaric container where
the organ is stored, totally immersed in the preservation
solution, with a residual free volume in the upper part con-
taining a gasmixture of 95%O2 and 5%CO2. The hyperbaric
chamber is enclosed into a conditioning system, which allows
the exact regulation and control of the temperature and
pressure (ranging form 0 to 2.5 ATA). The perfusion of the
organ with the preservation solution throughout the portal
vein is guaranteed by a peristaltic pump (Gilson Minupulse,
Villiers Le Bel, France) located outside the hyperbaric cham-
ber. A second peristaltic pump is used to generate a con-
tinuous movement of the preservation solution aiming to
enhance oxygen diffusion within the preservation solution.
Contrary to other HMP devices, which have been criticized
for their complicated logistics, the HHMP has been designed
to be easily carried by two persons allowing the possibility
to start the intervention immediately after procurement and
not only in the recipient’s transplant centre.
2.2. Experimental Design. Fed Sprague-Dawley rats (Char-
les-River Laboratories, Calco, Italy), weighing 250–300
grams, were anesthetized (Zoletil-100, Virbac, France) bet-
ween 9:00 and 10:00 a.m. and the abdomen opened with a
midline incision. Afterwards, heparin 500 IU/liter was injec-
ted through the infrahepatic vena cava and the portal vein
cannulated with a 16G angiocath. The liver was then flushed
out with 20mL of cold Celsior solution, immediately explan-
ted and flushed out again with 30mL of cold Celsior solution.
The livers were finally assigned to the following experimental
groups:
(1) baseline controls: liver tissue samples were immedi-
ately collected for the ultrastructural, histological,
and biochemical analysis;
(2) normobaric static preservation: livers were kept at 4◦C
in the HHMP under normobaric conditions (1 ATA)
immersed in the Celsior solution for 24 h. This group
mimics the current static storage used in clinical
transplantation;
(3) hyperbaric static preservation: livers were kept at 4◦C
in the HHMP under hyperbaric conditions (2 ATA)
immersed in the Celsior solution for 24 h. Compres-
sion and decompression were carried out progres-
sively at a rate of 0.2 ATA/min;
(4) normobaric dynamic preservation: livers were kept at
4◦C in the HHMP under normobaric conditions
(1 ATA) and continuously perfused with Celsior solu-
tion at 1mL/min/g liver for 24 h;
(5) hyperbaric dynamic preservation: livers were kept at
4◦C in the HHMP under hyperbaric conditions
(2 ATA) and continuously perfused with Celsior solu-
tion at 1mL/min/g liver for 24 h. Compression and
decompression were carried out progressively at a
rate of 0.2 ATA/min.
After 24 h of cold preservation, tissue samples were im-
mediately collected for the ultrastructural, histological, and
biochemical analysis. This preservation time was chosen
based on preliminary experiments showing that liver damage
increased progressively as function of the duration of preser-
vation (6, 12, and 24 h) and all the parameters studied be-
came significantly different from baseline after 24 h of the
current static storage.
All procedures involving rats were conducted in accor-
dance with internationally accepted principles for care of lab-
oratory animals (EEC Council Directive 86/609, OJ L358,1,
December 12, 1987) and the guidelines approved by the eth-
ical committee of our University.
2.3. Analytical Methods
2.3.1. Liver Ultrastructure. Liver samples were cut into small
pieces, fixed in 4% formaldehyde solution and postfixed in
The Scientific World Journal 3
1% OsO4 in 0.1M So¨rensen buffer. All the samples were then
dehydrated in alcohol and embedded in Epon. Thin sections
were double-stained with uranium and lead and observed
with a Philips 410 Electron Microscope.
2.3.2. Hepatic Glycogen. PAS staining of liver tissue was per-
formed to assess the glycogen stores. Briefly, the formalin-
fixed and paraffin-embedded specimens were cut into slices
of 4 μm thickness and mounted on glass slides. Thin sections
were deparaffinized, rehydrated in distilled water, and then
pretreated for 5min with 1% periodic acid (Fluka Chemie,
Buchs, Switzerland). After washing in mQ-water, the section
was left to react with the Schiff ’s reagent (Sigma-Aldrich,
Milan, Italy) for 15min at room temperature. Nuclei were
counterstained for 2min withMayer’s haematoxylin solution
(Sigma-Aldrich, Milan, Italy).
2.3.3. Hepatic Oxidative Stress
GSH and GSSG Assay. Liver specimens were homogenized
in 10 volumes of 0.1mol/L potassium-phosphate buffer (pH
7.4) containing 5mmol/L EDTA. Enzymatic determination
of total (GSH) and oxidized (GSSG) glutathione concentra-
tions were performed by precipitating tissue homogenates
with 15% sulfosalicylic acid (SSA) [16]. The supernatant was
processed for GSH determination by the GSSG recycling
procedure and incubated with 2-vinylpiridine and trietha-
nolamine for GSSG assay [17].
PSH and PSSG Assay. Protein sulfhydryls (PSHs) were mea-
sured with a modification of Elmann’s procedure in which
the SSA-precipitated proteins were resuspended in 700 μL of
6M guanidine, pH 6.0. Optical density was read spectropho-
tometrically at 412 and 530 nm before and after 30min of
incubation with 50 μL of 10mM5,5-dithiobis 2-nitrobenzoic
acid [18]. Protein-glutathione mixed disulfides (PSSG) were
measured as previously described [19]. Proteins were precip-
itated with 15% SSA containing 0.02M EDTA and then dis-
solved in 300 μL of 0.2M ammonium bicarbonate containing
8M urea and mixed with 5mg Na2BH4. Pentanol (50 μL)
was added to avoid frothing. After 20min, proteins were
precipitated with 100 μL of 15% SSA. The amount of GSH
in the supernatant obtained after centrifugation at 45,000 g
for 15min was enzymatically measured [16]. Results are
expressed as nmol GSH/mg protein.
RSNO Assay. The method described by Cook et al. [20],
which uses a mixture of SULF/NEDD (sulfanilamide/N-(1-
naphtyl)ethylenediamine dihydrochloride, neutral Griess) as
reagents, was used. Liver homogenate was suspended 1 : 4
in PBS (pH 7.4) containing 10mM N-ethylmaleimide and
4mM potassium ferricyanide, acidified with 25% SSA, and
centrifuged at 10,000×g for 10min. The supernatant was
added to 40 μL of 1% ammonium sulfamate, 200 μL of 0.4N
HCl containing 0.3% HgCl2 and 4.6% SULF, and 300 μL of
0.4N HCl containing 0.2% NEDD. After 30min of incu-
bation at 25◦C, the samples were spectrophotometrically
analyzed at 544 nm. Standards were prepared by reacting
equal molar reduced glutathione and nitrite in water. Total
protein concentration in liver homogenate did not differ sig-
nificantly among the experimental groups.
2.4. Endothelial and Inducible Nitric Oxide Synthase (NOS)
Gene Expression. The eNOS and iNOS gene expression was
assessed by using real-time PCR. Briefly, total RNA was ex-
tracted from liver samples using Trizol/chloroform extrac-
tion (Invitrogen, Carlsbad, CA, USA). Total RNA quality was
checked on ethidium bromide-stained gel and then 1 μg
reverse transcribed using SuperScript III RT (Invitrogen,
Carlsbad, CA, USA). Oligonucleotide primers pairs for eNOS
and iNOS were designed using Beacon Designer 2.0 software
(BioRad, Richmond, CA, USA) and then purchased from
Tema Ricerche s.r.l. (San Lazzaro, BO, Italy). As internal ref-
erence, primers for β-actin and β2-microglobulin were used.
Real-time quantitative PCR experiments were performed
utilizing iQSybr Green Supermix (BioRad, Richmond, CA,
USA) in the iCycler (BioRad, Richmond, CA, USA) instru-
ment. The fold changes in gene expression relative to the
levels obtained in baseline control rats, which were consi-
dered equal to 1, were analyzed and calculated with the
2−ΔΔCt method [21].
2.5. Statistical Analysis. Data were analyzed by means of the
two-way analysis of variance (ANOVA) with Bonferroni’s
post hoc test. Statistical analysis was performed by the SPSS
8.0 statistical package. Data are reported as mean values
± SE. Two-tailed P values less than 0.05 were regarded as
statistically significant.
3. Results
3.1. Liver Ultrastructure. After 24 h of the current static stor-
age, hepatocytes showed many cytoplasmatic vacuoles and
enlarged mitochondria with a reduced electron transparency
and granular electron opaque aggregates (very likely com-
posed by calcium salts) frequently found in the matrix. The
nuclei presented extensive clumping of the chromatin and
ribonucleoprotein components, while nucleoli were hardly
visualized. Sinusoidal cells were detached and their nuclei
were pycnotic (Figure 1(a)).
The ultrastructural alterations of hepatocytes and sinu-
soidal cells were clearly evident also in livers preserved
under hyperbaric static conditions (Figure 1(b)). In contrast,
normobaric dynamic preservation induced a significant
improvement of mitochondria morphology, which appeared
well preserved in most cases, even though some mitochon-
dria presented moderate swelling. However, changes in the
distribution of the nucleolar components and clumping of
the nucleoplasm ribonucleoproteins were still present. Fin-
ally, the sinusoidal cells were detached from hepatocytes
(Figure 1(c)).
Interestingly, hepatocytes of livers preserved with the
combination of continuous perfusion and hyperbaric oxygen
maintained an almost regular nuclear and cytoplasmatic
ultrastructure. Nucleoli were easily recognized with a normal
distribution of the ribonucleoproteins in most cases, while
glycogen stores and mitochondrial membranes and matrix
were well preserved, showing almost no matrix swelling and
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Figure 1: Transmission electron microscopy representative pictures of 24 h preserved livers. (a) Normobaric static preservation; (b) hyper-
baric static preservation; (c) normobaric dynamic preservation; and (d) hyperbaric dynamic preservation.
no membrane changes. Finally, sinusoidal cells appeared to
be characterized by pycnotic nuclei (Figure 1(d)).
3.2. Hepatic Glycogen. Although the periodic acid Schiff
staining allows only a qualitative evaluation, the hepatic gly-
cogen content was clearly depleted after the current static
storage (Figure 2(a)). While hyperbarism alone seems to
have only a marginal effect (Figure 2(b)), dynamic preser-
vation both with normobaric (Figure 2(c)) and hyperbaric
oxygen (Figure 2(d)) appears to guarantee the maintenance
of the baseline glycogen levels (Figure 2(e)).
3.3. Hepatic Oxidative Stress. The tissue content of GSH,
the major antioxidant in the liver, was significantly reduced
after the current static storage as compared to the baseline
level (Figure 3(a)). Taken into account the concomitant rise
of GSSG, the oxidized form of glutathione (Figure 3(b)),
one may conclude that the current static storage is asso-
ciated with the occurrence of a significant oxidative stress,
as shown by the increased GSSG/GSH ratio (Figure 3(c)).
While normobaric dynamic preservation had no effect on
these alterations, hyperbaric oxygen both under static and
dynamic conditions partially counterbalanced the redox
changes of the glutathione status.
The changes of PSH and PSSG mirror those of GSH and
GSSG (Figure 4).
Finally, the RSNO content, which represents an impor-
tant quote of nitric oxide (NO) bound to free thiols, was
reduced by 40% in livers preserved with the current static
storage. Again, hyperbaric oxygen both under static and dyn-
amic conditions prevented the RSNO depletion. In contrast,
no effect was seen when continuous perfusionwas performed
under normobaric condition (Figure 5).
3.4. Hepatic Gene Expression of eNOS and iNOS. The basal
preischemic gene expression of eNOS remained substantially
unchanged in the livers maintained for 24 h under the cur-
rent static cold storage. While perfusion alone had no evi-
dent effect, hyperbaric preservation was associated with an
increased eNOS gene expression although a statistical sig-
nificant difference was reached only in the group combin-
ing continuous perfusion and hyperbaric oxygenation
(Figure 6). In contrast, the gene expression of the iNOS
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Figure 2: Representative histological pictures of the liver PAS-stained glycogen. (a) Normobaric static preservation; (b) hyperbaric static
preservation; (c) normobaric dynamic preservation; (d) hyperbaric dynamic preservation; and (e) baseline controls.
isoform after 24 h preservation was similar in all the expe-
rimental groups to that observed in basal preischemic livers
(data not shown).
4. Discussion
The HMP has been shown to challenge the limits of the
current static storage in experimental liver transplantation,
by providing continuous nutrients and oxygen supply to the
organ and by removing the waste products, thus improving
parenchymal cell viability and function even after prolonged
cold ischemia [4, 9]. More recently, a pilot study has also
shown the safety and feasibility of liver preservation with
HMP in 20 liver transplanted patients [22, 23]. Although
active oxygenation of the preservation solution was not pro-
vided by the HMP used in this study, the pO2 levels in the
effluent perfusate remained relatively high and stable during
preservation as a result of ambient air interchange at the
organ chamber [22].
The hyperbaric hypothermic machine perfusion
(HHMP) described in our study represents an innovative ap-
proach against liver preservation injury, which combines the
oxygenation of the preservation solution with hyperbaric
oxygen to the continuous graft perfusion as performed by
the actual HMPs. We found that hyperbaric oxygen, besides
maintaining the positive effects of continuous perfusion on
ultrastructural damage and glycogen depletion, produces an
extra benefit by reducing the oxidative injury occurring
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Figure 3: Total glutathione (GSH) concentration (a), oxidized glutathione (GSSG) concentration (b), and oxidized/total glutathione (GSSG/
GSH) ratio (c) in baseline controls and 24 h preserved livers according to the study protocol. Data are expressed as means ± SE.
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Figure 4: Protein sulfhydryls (PSH) concentration (a) and protein-glutathione mixed disulfides (PSSG) concentration (b) in baseline con-
trols and 24 h preserved livers according to the study protocol. Data are expressed as means ± SE.
during preservation under normobaric conditions and by
inducing eNOS gene expression.
In these experiments, a significant oxidative damage
occurred after 24 h of static or dynamic normobaric preser-
vation, as indicated by the increased oxidized glutathione
and the GSSG/GSH ratio and by the reduced PSH. The
enhanced production of ROS during cold ischemia has been
already reported [24, 25] and only apparently it represents
a paradox. Indeed, the decrease of O2 concentration to the
hypoxic range of 5 to 0.5% [26] would lower mitochondrial
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respiration and enhance the reduction state of the mitochon-
drial redox centres, favouring the electron leak to molecular
oxygen and ROS production, mainly by the respiratory com-
plexes I and III [27]. Thus, oxygen acts as a double-edged
sword during cold preservation: its supply is mandatory to
support aerobic metabolism and maintain ATP levels in the
hepatocytes, but it is also potentially harmful by increasing
the generation of toxic ROS.
In contrast, preservation with hyperbaric oxygen was
associated with decreased oxidative injury. Although previ-
ous studies have shown that hyperbaric oxygen reduce lipid
peroxidation in several prooxidant experimental models [12,
28, 29], the underlying mechanisms of protection are still
elusive. It can be hypothesized that hyperbaric oxygen fa-
vours an efficient electron transfer through the OXPHPOS
complexes, as suggested by the great improvement of ultra-
structural mitochondrial damage observed in a previous
work [30], and reduces ROS formation, which eventually
may prevent the GSH oxidative consumption.
However, under static conditions, hyperbaric oxygen re-
duces oxidative damage without improving mitochondrial
damage, thus suggesting the existence of other mechanisms.
Nitrosothiols are unstable thioesters exerting different intra-
and extracellular functions only in part defined [31]. Recent
experimental evidences suggest that protein S-nitrosylation
could modulate ROS production and limit oxidative damage
during ischemia reperfusion in the heart and liver [32]. In
our experiments, liver preserved under hyperbaric condi-
tions maintain the baseline nitrosothiols levels, which are
instead significantly reduced after normobaric preservation.
Since protein S-nitrosylation has emerged as an effector of
NO bioactivity [33], it is also tempting to speculate that the
prevention of nitrosothiols depletion may be related to an
increased generation of NO from eNOS, as suggested by the
induction of its gene expression in livers preserved under
hyperbaric conditions.
Beside the effect on protein S-nitrosylation and oxidative
stress, a greater availability in the vascular bed of eNOS gene-
rated NO may have other potential benefits by favouring
vasodilatation and capillary flow and by reducing neutrophil
adherence during reperfusion of the graft [13–15]. As we
were not able to observe any significant effect on iNOS gene
expression, our results support the finding of previous stu-
dies that hyperbaric oxygen is able to modulate NO produc-
tion in several organs and different experimental conditions
by selectively inducing eNOS while inhibiting iNOS produc-
tion [13–15].
Although it can be expected that the prevention during
cold preservation of mitochondrial damage, glycogen deple-
tion, and oxidative injury, together with the increased endo-
thelial NO generation, can favour a rapid recovery of liver
graft viability after reperfusion, whether the use of HHMP
can effectively improve the post-transplant outcome com-
pared to the current static storage remains undetermined and
needs to be assessed in experimental liver transplantation,
which was not technically feasible in the present study.
Besides that, several other aspects have to be tested in
order to optimize the use of the HHMP, including the
type of preservation solution, the rate and modalities of
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in baseline controls and 24 h preserved livers according to the study
protocol. Values were determined by real-time PCR and expressed
as fold induction over baseline control rats. Data are expressed as
means ± SE.
organ perfusion, and the degree of hyperbarism. In the pre-
sent study, we decided to minimize the number of the expe-
rimental variables in order to selectively assess the effect of
hyperbarism combined or not with the continuous perfusion
of the liver. With this objective in mind, we have utilized a
preservation solution currently employed in the static cold
storage as well as an intermediate rate of perfusion and a
medium level of hyperbarism among those employed in the
studies previously published [4, 7, 9, 15, 22, 34]. Of course,
it means that the use of preservation solutions specifically
designed for machine perfusion systems or different perfu-
sion dynamics would likely produce some additional benefit.
A potential pitfall associated with the continuous perfu-
sion of the graft is represented by the sinusoidal endothelial
cell (SEC) damage, which likely ensues, beside the well-
established detrimental effects of hypothermia, from a
shear-stress phenomenon [9, 35], thus counterbalancing the
potential benefits on cell metabolism. Several attempts to
improve SEC viability are under investigation, including
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modifications in the composition of the preservation solu-
tions and in the modalities of organ perfusion [7, 9, 34, 36].
In our experiments, while continuous perfusion with Celsior
solution at 1mL/min/g liver with hyperbaric oxygen did not
appear to be fully protective, we found that lowering the
rate of perfusion flow to 0.5–0.2mL/min/grams of liver was
associated with a better preservation of the sinusoidal lining
(data not shown).
In conclusion, preservation by means of the present in-
novative HHMP, which combines the oxygenation of the
preservation solution with hyperbaric oxygen to the continu-
ous graft perfusion, reduced liver injury possibly by pre-
venting the mitochondrial damage, glycogen depletion and
oxidative damage which develop after the currently used
static storage. Interestingly, only the use of hyperbaric oxygen
was associated to a blunted oxidative stress and an increased
eNOS gene expression. These results represent the rationale
background to test the HHMP in experimental liver trans-
plantation models.
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